For Generics, A Victory Lap – And A Warning – On Drug Shortages

 
• By Nielsen Hobbs
  
AAM’S JONATHAN KIMBALL, LUPIN’S ALOK SONIG, MAYNE PHARMA’S HEM PANDYA, AND WASHINGTON UNIVERSITY’S ANTHONY SARDELLA DISCUSS WHAT WENT RIGHT WITH THE GENERIC INDUSTRY’S COVID RESPONSE.
AAM’S JONATHAN KIMBALL, LUPIN’S ALOK SONIG, MAYNE PHARMA’S HEM PANDYA, AND WASHINGTON UNIVERSITY’S ANTHONY SARDELLA DISCUSS WHAT WENT RIGHT WITH THE GENERIC INDUSTRY’S COVID RESPONSE. • Source: Nielsen Hobbs

More from Generics

More from Products